Skip to main content

Table 1 Demographic characteristics and health care provider for patients initiating therapy with duloxetine versus venlafaxine XR

From: Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder

Characteristic

Duloxetine Group

(n = 9,641)

Venlafaxine XR Group

(n = 8,514)

p-value

Age (y), mean ± SD

45.0 ± 11.4

42.4 ± 12.2

.0001

Age group (%)

  

.0001

   18-35 y

20.9

29.3

 

   36-50 y

42.6

40.9

 

   51-65 y

36.5

29.8

 

Female (%)

73.6

71.5

.001

Plan type (%)

 

(NS)

.061

   Health maintenance organization

26.6

27.9

 

   Indemnity

5.4

4.7

 

   Preferred provider

49.9

48.7

 

   Point of service

16.1

16.3

 

   Other or unknown

2.0

2.4

 

Region (%)

  

.0001

   East

17.1

16.6

 

   Midwest

39.3

43.7

 

   South

24.1

21.4

 

   West

19.5

18.3

 

Prescribed by psychiatrists (yes vs. no)

46.2

41.8

.0001

  1. XR = extended-release. Indemnity - a type of fee-for-service medical plan that reimburses the patient and/or provider as expenses are incurred. All comparisons of demographics between cohorts are statistically significant (at least P < 0.001), except those marked by (NS = Not statistically significant).